VP, Global Medical Lead - Vaccines

The VP, Global Medical Lead (GML) mRNA portfolio is a key senior business leadership role, reporting to the SVP, Global Medical Vaccine Head, a member of GSK’s Chief Patient Officer Team. The leader will have full responsibility for the Global Medical Strategy for the mRNA Flu, Covid and Combination portfolio. They will translate the science to shape medical practice, deliver positive health impact for patients and provide decision‑makers worldwide with the evidence and confidence they need on GSK therapies and vaccines. The role will be accountable for the medical strategic direction of the Global Asset/Vaccine Medical Leadership Team and will integrate innovative strategies to support future product launches and advance patient care.

The incumbent will partner with key markets to inform all evidence, asset‑vaccine development and strategic deliverables, and will work across Commercial and R&D to deliver value for patients. They will also be a member of additional matrix teams, including the Medicines/Vaccine Development Team and the Medicine/Vaccine Commercial Team, providing medical insight and expertise throughout the life‑cycle.

• Lead both the cross‑functional global medical team (GMT) and oversee the global medical portfolio budget.
• As convenor and chair of the GMT, jointly accountable with top‑tier markets for developing the global medical brand strategy and plans by convening the GMT.
• Set direction along the strategic framework of the medical brand plan, including setting scientific objectives, owning the medical scientific narrative and the integrated communication plan.
• Accountable for directing and coordinating global resources to generate data and create content to support priority markets, leveraging the expertise of the Global data generation and scientific communication teams.
• Represent medical as an independent strategic partner in cross‑functional strategy meetings, proactively offering options for innovative medical strategies.
• Provide focused input at key inflection points during development (e.g., from commit to Phase 2 onwards and throughout the lifecycle).

• Maximize the positive impact for patients and GSK from early development to maturity (defined as no further significant clinical evidence generation potential).
• Act as a partner to the Vaccine Development Lead and Vaccine Commercialisation Lead, ensuring integrated and thoughtful insights from a diverse stakeholder set to shape the medicines/vaccine’s vision, development strategy, and clinical development in the early phases, and for refining medical strategy as clinical evidence is generated.
• Ensure that medical insights from priority markets are incorporated into the GMT to inform all evidence, product development, and asset strategy deliverables.
• Accountable for leading the GMT in the development and delivery of the Global medical product strategy and associated global deliverables, enabling prioritized LOCs to execute the strategy and deliver positive patient impact locally.
• Ensure that the data generation plan aligns to identified unmet needs and prioritized evidence gaps, addressing key medical and market access requirements and maximizing asset competitiveness from launch through lifecycle management for priority markets.
• Lead a global matrix team that executes on generation of evidence, publication plans and creation of content to support priority markets to shape medical practice and differentiate our medicines and vaccines.
• Act as medical Launch lead, partnering with cross‑functional partners and priority markets to ensure timely and ambitious launches.
• Input into the cross‑functional team, in partnership with the VDL and VCL, for the development of ambitious LCI plans.
• Lead regular assessment of medical plan impact utilizing the medical impact framework, ensuring plan reviews and proactive communication of impact measures to key stakeholders as required.
• Oversee asset budget to ensure that resources are deployed against the highest impact tactics.
• Ensure that Global deliverables are produced on time based on market needs.
• Use a Global mindset, incorporating local perspectives, to strategy development and decision making; partner with priority markets to understand their needs and balance options to achieve set‑out goals.

• Maintains the patient at the centre of everything we do.
• Full immersion in the science, disease area and business to be a true and equal partner to R&D, Commercial and Key LOCs.
• Maintain up‑to‑date knowledge of scientific data and competitive intelligence and drive transformation of knowledge and medical insights into patient‑centred strategic thinking and action plans.
• Outstanding matrix leadership through the creation of a collaborative and cross‑functional environment by fostering shared accountability and responsibility for delivery of specific goals and projects and encouraging employees to work with diverse skill sets and learn from each other.
• Seek out, actively listen to and understand the needs of key markets and ensure they are appropriately reflected in the global strategy, inclusive of evidence generation and all other deliverables.
• Assess and understand the external environment, inclusive of the competitor landscape, to bring insights together to develop a clear, simple, compelling medical strategy to improve outcomes for patients.
• Adopt a visionary and intuitive mindset, to anticipate current and future market value‑drivers and evidence gaps and seek innovative solutions to them to support the long‑term ambition for the asset/vaccine and its ultimate benefit for patients.
• Quickly adapt to unexpected external changes, understanding impact to strategy and ability to articulate implications for both R&D and commercial.
• Integrate and synthesize deep understanding of the end‑to‑end asset development processes, inclusive of commercialization and interconnectivities to deliver practice change and impact for patients.

• Be a role model to all GSK employees, setting the right tone from the top while embedding a culture of performance underpinned by GSK Purpose, strategy and culture.
• Visibly leads with authenticity and confidence to gain followship for a workable plan, even in ambiguity.
• Creates cohesion and fellowship amongst the Medical Asset/Portfolio Leadership Team, especially with key/priority LOCs, maximizing its effectiveness as a decision‑making unit, external impact and fostering collective accountability for success.
• Communicates consistently and with impact, with the goal that everyone who works on an asset understands and can implement the strategy.
• Adapt approaches for seeking input and feedback to accommodate cultural differences in LOCs.
• Outstanding leader of people, directly and indirectly, creating clarity in expectations and holding oneself and team accountable.
• Creates an environment where our people can develop and thrive while holding a high‑performance bar across organization which he/she leads.
• Identify, attract, develop and retain talent and organisational capability for the future.
• Leads through uncertainty and ambiguity driving a culture of continuous improvement while building an agile learning organization.

• Builds strong relationships across the enterprise to maximise synergies and impact.
• Fully understands the GSK Code and relevant policies governing our work, enabling team members and self to always do the right thing.
• Understands and proactively identifies risk developing mitigation plans aligned to our Internal Control Framework.
• Develop, gain approval for, and manage the annual budget required to deliver the objectives in line with defined processes and policies.

• MD/MBBS/PharmD or PhD in clinical/scientific discipline related to medicine/pharmacology.
• Experience in a global medical affairs role leading a launch asset.
• Experience in a medical affairs leadership role in country; either as a Country Medical Director in a smaller market or a Therapy Area Lead in a larger market.
• Clinical development experience.
• Experience supporting an indication as part of a cross‑functional team including creation of a competitive and accessible TPP.
• Experience in medical support for briefing documents for regulatory interactions and payor dossiers.
• General understanding of statistics, safety, regulatory requirements.

• Strong preference for prior US experience.
• Strong demonstration of strategic and medical leadership and scientific agility.
• Track record of building and maintaining a deep and continued connection to medical practice and healthcare delivery.
• Experience of launching medicines or vaccines either at global or local level.
• Examples of curiosity and agility with the ability to pivot to new areas of focus, assimilate information rapidly and identify critical questions that will drive decision‑making and planning.
• Skilled at simultaneous consideration of scientific data and practical healthcare delivery needs from diverse health systems to optimise medical implementation of innovation.
• Evidence of innovative digital and AI leadership within prior medical roles.
• Collaborative matrix management skills with a focus on leading diverse groups (e.g., cultural, geographical, functional) to achieve excellent results in shared goals.
• Strong listening, communication & collaborative team working and leadership skills, as the role involves interface with a wide range of stakeholders internally and externally.
• Examples of where cross‑functional collaboration and ability to influence various stakeholders across different levels in the matrix organisation has been harnessed.
• Demonstrated deep relationships and interaction with external experts (physicians) in the therapeutic area – requiring a high level of medical knowledge/experience, understanding of patient management, and strong clinical judgement on benefit‑risk significance.
• Impactful communication and influencing skills with the ability to distil complexity down to what matters most to our stakeholders.
• Ability to manage ambiguity, evaluate benefit and risk and take appropriate accountability for decision making – enterprise leader with business acumen and agility to create business outputs in a VUCA (Volatility, Uncertainty, Complexity, Ambiguity) environment.
• Strong financial/budget and project management skills as well as business acumen.
• Maintenance of high professional standards and adherence to internal and external codes of practice.
• Ability to prioritise work for self and team.

If you are based in Cambridge, MA; Waltham, MA; Rockville, MD; or San Francisco, CA, the annual base salary for new hires in this position ranges $297,000 to $495,000.

The US salary ranges take into account a number of factors including work location within the US market, the candidate’s skills, experience, education level and the market rate for the role. In addition, this position offers an annual bonus and eligibility to participate in our share‑based long‑term incentive program which is dependent on the level of the role. Available benefits include health care and other insurance benefits (for employee and family), retirement benefits, paid holidays, vacation, and paid caregiver/parental and medical leave.

GSK is an Equal Opportunity Employer. This ensures that all qualified applicants will receive equal consideration for employment without regard to race, color, religion, sex (including pregnancy, gender identity, and sexual orientation), parental status, national origin, age, disability, genetic information (including family medical history), military service or any basis prohibited under federal, state or local law.